Cytosorbents Crp (CTSO : NASDAQ)
Common Stock
$4.11
USD
+1.05 (34.31%)
Last updated: 2026-10-16
Follow CTSO
CTSO
Cytosorbents Crp
WealthAwesomePerformance
1 Day
+34.31%
1 Week
+8.44%
1 Month
-28.27%
YTD
+761.64%
Key Statistics
Market Cap
$12.95M
52W High
$17.60
52W Low
$2.84
P/E Ratio
-
50 Day MA
$5.74
200 Day MA
$9.92
Beta
1.37
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/16/2026 | $3.01 | $4.60 | $3.01 | $4.11 | $4.11 | 684,831 |
| 10/15/2026 | $2.96 | $3.09 | $2.84 | $3.06 | $3.06 | 10,827 |
| 10/14/2026 | $3.39 | $3.46 | $2.96 | $3.09 | $3.09 | 16,511 |
| 10/13/2026 | $3.65 | $3.65 | $3.42 | $3.46 | $3.46 | 10,170 |
| 10/12/2026 | $3.65 | $3.82 | $3.51 | $3.59 | $3.59 | 8,340 |
| 10/9/2026 | $3.67 | $3.80 | $3.59 | $3.79 | $3.79 | 6,233 |
| 10/8/2026 | $3.81 | $3.81 | $3.67 | $3.73 | $3.73 | 10,837 |
| 10/7/2026 | $4.00 | $4.06 | $3.84 | $3.87 | $3.87 | 6,377 |
| 10/6/2026 | $4.07 | $4.29 | $3.89 | $3.96 | $3.96 | 24,863 |
| 10/5/2026 | $3.85 | $4.05 | $3.66 | $3.96 | $3.96 | 8,377 |
Analyst Price Targets
Based on 1 analyst covering CTSO · as of Oct 5, 2026
Wall Street analysts forecast CTSO stock price to rise 1055.7% over the next 12 months.
Consensus
Hold3.00 / 5.00
Avg. Target
US$47.50
+1055.7% Upside
Current Price
US$4.11
Last close
Analyst Breakdown (1 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CTSO's historical volatility
30-Day Vol
874.6%
Annualized
90-Day Vol
527.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$4.91
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$4.36 | US$0.21 – US$89.19 |
| 60 trading days | US$4.63 | US$0.06 – US$330.40 |
| 90 trading days | US$4.91 | US$0.03 – US$915.06 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Cytosorbents Crp
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses, bilirubin in liver failure, myoglobin in trauma and critical illnesses, and inflammatory mediators and blood thinners in cardiac surgery applications, as well as to remove antithrombotic drugs and inflammatory mediators in cardiothoracic surgery applications. The company also develops DrugSorb-ATR antithrombotic removal system, an investigational device to reduce the severity of perioperative bleeding in high-risk surgery due to blood thinning drugs; ECOS-300CY to reduce cytokines and other inflammatory mediators when used in an ex vivo organ perfusion system; VetResQ, a broad-spectrum blood purification adsorber for the treatment of septic shock, toxic shock syndrome, toxin-mediated diseases, pancreatitis, trauma, liver failure, heat stroke, and lung injury in animals; and PuriFi, an advanced hemoperfusion pump for blood purification therapies. In addition, it develops HemoDefend-BGA, a blood purification technology platform to reduce anti-A and anti-B antibodies in plasma and whole blood. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.
Financials
- Revenue (TTM)
- $37.22M
- EBITDA
- $-10.35M
- Profit Margin
- -48.94%
- ROE (TTM)
- -336.21%
- EPS (Diluted)
- -5.80
- Book Value
- -0.24
Classification
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Group
- Health Care Equipment & Services
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About CTSO.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| FRGT | Freight Technologies Inc | $1.48 | +695.71% |
| GP | GreenPower Motor Company Inc | $1.61 | +361.98% |
| XLAB | Exascale Labs Holdings Inc. Class A Common Stock | $2.35 | +72.79% |
| LESLQ | Leslie's, Inc. | $0.05 | +56.67% |
| AACG | ATA Creativity Global | $0.95 | +50.79% |
| EURKR | Eureka Acquisition Corp Right | $0.40 | +50.02% |
| LHSW | Lianhe Sowell International Group Ltd Ordinary Shares | $0.70 | +46.66% |
| HODO | House of Doge Inc. | $0.09 | +37.78% |